Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:e81
doi: 10.1161/01.RES.0000265132.99997.d3
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Norata, G. D.
Right arrow Articles by Catapano, A. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Norata, G. D.
Right arrow Articles by Catapano, A. L.
(Circulation Research. 2007;100:e81.)
© 2007 American Heart Association, Inc.


Letter to the Editor

Triglyceride-Rich Lipoproteins From Normotrygliceridemic Subjects and Hyperlipidemic Patients Differently Affect Endothelial Cell Activation and Gene Expression Patterns

Giuseppe D. Norata, Alberico L. Catapano

Centro SISA per lo Studio della Aterosclerosi, Ospedale Bassini, Cinisello Balsamo, Milano Department of Pharmacological Sciences, University of Milan Italy


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

We read with interest the article by Ting et al1 showing that post-prandial triglyceride-rich lipoproteins (PP-TGRL) from healthy human volunteers (NTG) fail to promote endothelial inflammation but increase the tumor necrosis factor-{alpha} response of endothelial cells. We would like to add further information on this topic recently obtained in our laboratory2,3 that may contribute to the understanding of the role of TG-rich lipoproteins in modulating endothelial function(s).

Ting et al, showed that PP-TGRL are unable to elicit pro-inflammatory responses and this finding is based on the lack of effect of PP-TGRL on ICAM-1, VCAM-1 and E-selectin mRNA expression. An observation confirmed by the lack of monocyte recruitment by endothelial cells exposed to PP-TGRL. However, and consistent with our findings,2,3 postprandial TGRL per se activated p38MAPK a key pathway of intracellular signaling in inflammation.

In addition we showed that postprandial TGRL from type IV hyperlipidemic patients induce to a larger extent, compared with fasting TGRL, phosphorylation of p38 MAPK, CREB and IKB-{alpha} in human endothelial cells and increase the DNA binding activity of CREB, NFAT and NF-kB.3 These results prompted us to investigate the differences between PP-TGRL form NTG subjects and HTG patients on endothelial cell gene expression.2,4,5 We observed the induction by PP-TGRL form HTG patients but not by NTG subjects of a large set of proinflammatory genes including VCAM-1, PECAM-1, ELAM-1, ICAM-1, P-selectin, MCP-1, IL-6, TLR-4, CD40, ADAMTS1 and PAI-1. Furthermore, in vivo, the endothelium-dependent flow mediated dilatation (FMD) decreased in both NTG and HTG subjects . . . [Full Text of this Article]